Compugen shareholders approve all 2026 AGM items
Compugen confirms all proposals at its 2026 Annual General Meeting were approved and ties the results into its existing Form F-3 registration statement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Compugen Ltd. (CGEN) reports that it held its 2026 Annual General Meeting of Shareholders on September 10, 2026. All proposals presented to shareholders at the meeting were approved by the requisite majority.
The report states that this information is incorporated by reference into Compugen’s existing Registration Statement on Form F-3, File No. 333-295989.
Key Figures
Key Terms
Form 6-K regulatory
foreign private issuer regulatory
incorporated by reference regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Compugen Ltd. (CGEN) announce in this Form 6-K?
How does this Form 6-K relate to Compugen’s Form F-3 registration statement?
Where were the proxy materials for Compugen’s 2026 AGM previously filed?
AI-generated analysis. How Rhea-AI works. Not financial advice.